ES2198001T3 - Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular. - Google Patents

Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular.

Info

Publication number
ES2198001T3
ES2198001T3 ES97934498T ES97934498T ES2198001T3 ES 2198001 T3 ES2198001 T3 ES 2198001T3 ES 97934498 T ES97934498 T ES 97934498T ES 97934498 T ES97934498 T ES 97934498T ES 2198001 T3 ES2198001 T3 ES 2198001T3
Authority
ES
Spain
Prior art keywords
methyl
compound
hydrogen
alkyl
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934498T
Other languages
English (en)
Spanish (es)
Inventor
Donna Mary Huryn
Dennis Dalton Keith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2198001T3 publication Critical patent/ES2198001T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES97934498T 1996-07-29 1997-07-19 Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular. Expired - Lifetime ES2198001T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
US22079P 1996-07-29

Publications (1)

Publication Number Publication Date
ES2198001T3 true ES2198001T3 (es) 2004-01-16

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934498T Expired - Lifetime ES2198001T3 (es) 1996-07-29 1997-07-19 Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular.

Country Status (23)

Country Link
US (2) US5856517A (enExample)
EP (1) EP0915872B1 (enExample)
JP (1) JP2000516589A (enExample)
KR (1) KR20000029637A (enExample)
CN (2) CN1495182A (enExample)
AR (1) AR008267A1 (enExample)
AT (1) ATE240318T1 (enExample)
AU (1) AU739742B2 (enExample)
BR (1) BR9711605A (enExample)
CA (1) CA2262092A1 (enExample)
CO (1) CO4900055A1 (enExample)
CY (1) CY2483B1 (enExample)
DE (1) DE69722003T2 (enExample)
DK (1) DK0915872T3 (enExample)
ES (1) ES2198001T3 (enExample)
HR (1) HRP970414A2 (enExample)
MA (1) MA24287A1 (enExample)
PE (1) PE91698A1 (enExample)
PT (1) PT915872E (enExample)
SA (1) SA97180473A (enExample)
TR (1) TR199900157T2 (enExample)
WO (1) WO1998004552A1 (enExample)
ZA (1) ZA976492B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2208612C2 (ru) * 1998-03-17 2003-07-20 Ф.Хоффманн-Ля Рош Аг Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
WO2001044235A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
EP1242420A2 (en) * 1999-12-16 2002-09-25 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) * 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
WO2006086484A1 (en) 2005-02-09 2006-08-17 Arqule, Inc. Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
EP2170870B1 (en) 2007-06-22 2014-03-05 ArQule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
US6030994A (en) 2000-02-29
TR199900157T2 (xx) 1999-04-21
ZA976492B (en) 1998-01-29
DE69722003D1 (de) 2003-06-18
CN1226247A (zh) 1999-08-18
SA97180473A (ar) 2005-12-03
PE91698A1 (es) 1998-12-24
AU739742B2 (en) 2001-10-18
CN1495182A (zh) 2004-05-12
JP2000516589A (ja) 2000-12-12
EP0915872A1 (en) 1999-05-19
BR9711605A (pt) 1999-08-24
KR20000029637A (ko) 2000-05-25
CY2483B1 (en) 2005-06-03
HRP970414A2 (en) 1998-06-30
US5856517A (en) 1999-01-05
DE69722003T2 (de) 2004-04-01
EP0915872B1 (en) 2003-05-14
MA24287A1 (fr) 1998-04-01
CN1151149C (zh) 2004-05-26
CA2262092A1 (en) 1998-02-05
AU3769097A (en) 1998-02-20
WO1998004552A1 (en) 1998-02-05
ATE240318T1 (de) 2003-05-15
AR008267A1 (es) 1999-12-29
PT915872E (pt) 2003-09-30
CO4900055A1 (es) 2000-03-27
DK0915872T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
ES2198001T3 (es) Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular.
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
AU708167B2 (en) Intimal hypertrophy inhibitors
US6228877B1 (en) Substituted pyrroles
JP2010222366A (ja) 細胞増殖の阻害のための置換ビスインドリルマレイミド類
EP3152192A1 (en) Novel quinoline derivatives and their use in neurodegenerative diseases
De la Torre et al. [60] Fullerene–flavonoid dyads
JP2000505096A (ja) 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
CA2214744C (en) 3-(bis-substituted phenylmethylene)oxindole derivatives
AU2015362700B2 (en) Indole and azaindoles derivatives and their use in neurodegenerative diseases
US5891901A (en) Substituted pyrroles
ES2372306T3 (es) 4-cromenonil-1,4-dihidropiridincarbonitrilos y su uso.
ES2233677T3 (es) Tienopirrolidininonas.
MXPA99000961A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
JPH01287070A (ja) 新規の１―アリールスルホニル―２―ピロリジノン誘導体、それらの製造方法及び得られる新規の中間体、それらの薬剤としての使用並びにそれらを含有する組成物
US3864351A (en) 1-({60 -Carboxymethoxybenzoyl-2-(2{40 -pyridyl)benzimidazoles
SU1028246A3 (ru) Способ получени производных пирролидина
KR100371122B1 (ko) 하이드라진 유도체
MXPA99001027A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
MXPA99001026A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
MXPA00008923A (en) Substituted bisindolymaleimides for the inhibition of cell proliferation